All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

36

Reset

36 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Maridebart cafraglutideAMG 133Phase 314 trials

    Amgen · Obesity, Overweight, Obstructive Sleep Apnea

  • HRS9531Phase 313 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Type 2 Diabetes, Chronic Management of Body Weight, Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  • NNC0487-0111Phase 312 trials

    Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • ElecoglipronPhase 39 trials

    AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight

  • IBI362Phase 38 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Obesity, Overweight, Sleep Apnea

  • CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials

    Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia

  • HRS-1893Phase 35 trials

    Shandong Suncadia Medicine Co., Ltd. · Obstructive Hypertrophic Cardiomyopathy, Heart Failure With Preserved Ejection Fraction, Hypertrophic Cardiomyopathy

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials

    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy

  • ZiltivekimabPhase 34 trials

    Novo Nordisk · Acute Myocardial Infarction (AMI), Myocardial Infarction, Heart Failure

  • for organ preservation in transplantationCustodiol-N, CustodiolPhase 32 trials

    Dr. F. Köhler Chemie GmbH · Heart Transplantation, Kidney Failure, Liver Failure, Chronic

  • HiCM-188 therapyPhase 32 trials

    HELP Therapeutics Co., Ltd. · Heart Failure

  • Tasly Pharmaceutical Group Co., Ltd · Heart Failure, Chronic Heart Failure With Preserved Ejection Fraction

  • AtibuclimabIC14Phase 24 trials

    Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • AC01Phase 22 trials

    AnaCardio AB · Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Reduced Ejection Fraction

  • BimagrumabLY3985863, BYM338Phase 22 trials

    Eli Lilly · Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction

  • CDR132LPhase 22 trials

    Novo Nordisk · Heart Failure

  • CRD-4730Phase 22 trials

    Cardurion Pharmaceuticals, Inc. · Catecholaminergic Polymorphic Ventricular Tachycardia, Heart Failure With Reduced Ejection Fraction (HFrEF)

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

  • TX000045Phase 22 trials

    Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary

  • AZD3427Phase 21 trial

    AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure

  • AZD5462Phase 21 trial

    AstraZeneca · Chronic Heart Failure

  • BMS-986435MYK-224Phase 21 trial

    Bristol Myers Squibb · Heart Failure

  • COR-1167Phase 21 trial

    Corteria Pharmaceuticals · Worsening Heart Failure

  • EDG-15400Phase 21 trial

    Edgewise Therapeutics, Inc. · Heart Failure With Preserved Ejection Fraction

  • JK07Phase 21 trial

    Salubris Biotherapeutics Inc · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction

  • JTT-861Phase 21 trial

    Shionogi Inc. · Chronic Heart Failure

  • PF-07328948Phase 21 trial

    Pfizer · Heart Failure

  • REGN5381Phase 21 trial

    Regeneron · Heart Failure

  • SPC1001Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SRD-001Phase 21 trial

    Sardocor Corp. · Congestive Heart Failure, Heart Failure, Systolic, Heart Failure

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.